DIFFERENTIAL METHYLATION LEVEL OF CPG LOCI THAT ARE DETERMINATIVE OF KIDNEY CANCER
摘要
<p>The present disclosure provides for and relates to the identification of novel biomarkers for diagnosis and prognosis of kidney cancer. The biomarkers of the invention show altered methylation levels of certain CpG loci relative to normal kidney tissue, as set forth.</p>
申请公布号
WO2015120142(A2)
申请公布日期
2015.08.13
申请号
WO2015US14604
申请日期
2015.02.05
申请人
HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY;BOARD OF DIRECTORS OF THE LELAND STANFORD JUNIOR UNIVERSITY
发明人
LASSEIGNE, BRITTANY, N.;MYERS, RICHARD, M.;ABSHER, DEVIN;BROOKS, JAMES, D.
